검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | Mesalamine |
Overview Company | Tanta University |
Overview Modality | ANTIBODY |
Overview Target | Hermanski-Pudlak Syndrome |
Overview Indication | Ulcerative Colitis |
Overview Phase | PHASE_2 |
Overview Status | RECRUITING |
MoA Mechanism | binds to mannose-related receptor |
MoA Biomarker | Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot Trial |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse, In vitro |
PK/PD Experiment | pharmacokinetic |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse, In vitro |
Toxicology Major finding | Oral Cobalt Coordination Microparticles for Targeted Inflammatory Bowel Disease Treatment.. Inflammatory bowel diseases (IBD) induce serious symptoms, but the current treatment approaches suffer from low bioavailability, poor patient compliance, and limited efficacy. Therefore, the development of advanced drug delivery systems for oral drugs is urgently needed. In this study, a hypoxia-responsive … |
Clinical Data Tier / Score | A · 32 |
Clinical Program phase | PHASE_2 |
Clinical Clinical sync | 2026년 7월 13일 (1일 전) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | Mesalamine |
Overview Company | Tanta University |
Overview Modality | ANTIBODY |
Overview Target | Hermanski-Pudlak Syndrome |
Overview Indication | Ulcerative Colitis |
Overview Phase | PHASE_2 |
Overview Status | RECRUITING |
MoA Mechanism | binds to mannose-related receptor |
MoA Biomarker | Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot Trial |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse, In vitro |
PK/PD Experiment | pharmacokinetic |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse, In vitro |
Toxicology Major finding | Oral Cobalt Coordination Microparticles for Targeted Inflammatory Bowel Disease Treatment.. Inflammatory bowel diseases (IBD) induce serious symptoms, but the current treatment approaches suffer from low bioavailability, poor patient compliance, and limited efficacy. Therefore, the development of advanced drug delivery systems for oral drugs is urgently needed. In this study, a hypoxia-responsive … |
Clinical Data Tier / Score | A · 32 |
Clinical Program phase | PHASE_2 |
Clinical Clinical sync | 2026년 7월 13일 (1일 전) |
추천 비교
추천 비교